These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10802809)

  • 21. Esotropia in a child treated with a scopolamine patch for drooling.
    Good WV; Crain LS
    Pediatrics; 1996 Jan; 97(1):126-7. PubMed ID: 8545207
    [No Abstract]   [Full Text] [Related]  

  • 22. [Intoxication psychosis following the administration of scopolamine drops into the conjunctival sac].
    Krynyckyj V; Janovský F; Sedivec V
    Cesk Psychiatr; 1966 Dec; 62(6):405-8. PubMed ID: 5980803
    [No Abstract]   [Full Text] [Related]  

  • 23. Pramipexole-induced psychosis in Parkinson's disease.
    Li CT; Tsai SJ; Hwang JP
    Psychiatry Clin Neurosci; 2008 Apr; 62(2):245. PubMed ID: 18412854
    [No Abstract]   [Full Text] [Related]  

  • 24. Clozapine treatment of psychosis in patients with Parkinson's disease.
    Friedman JH
    J Clin Psychiatry; 1994 Feb; 55(2):79. PubMed ID: 8077160
    [No Abstract]   [Full Text] [Related]  

  • 25. Dopaminergic psychosis in advanced Parkinson's disease.
    Fischer P; Danielczyk W; Simanyi M; Streifler MB
    Adv Neurol; 1990; 53():391-7. PubMed ID: 2122647
    [No Abstract]   [Full Text] [Related]  

  • 26. Ziprasidone in Parkinson's disease psychosis.
    Connemann BJ; Schönfeldt-Lecuona C
    Can J Psychiatry; 2004 Jan; 49(1):73. PubMed ID: 14763682
    [No Abstract]   [Full Text] [Related]  

  • 27. Withdrawal symptoms after discontinuation of transdermal scopolamine therapy: treatment with meclizine.
    Patel PN; Ezzo DC
    Am J Health Syst Pharm; 2009 Nov; 66(22):2024-6. PubMed ID: 19890085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychosis due to transdermally administered scopolamine.
    MacEwan GW; Remick RA; Noone JA
    CMAJ; 1985 Sep; 133(5):431-2. PubMed ID: 4027811
    [No Abstract]   [Full Text] [Related]  

  • 29. Toxic psychosis from sleeping medicines containing scopolamine.
    Bernstein S; Leff R
    N Engl J Med; 1967 Sep; 277(12):638-9. PubMed ID: 4378229
    [No Abstract]   [Full Text] [Related]  

  • 30. Clozapine in drug-induced psychosis in Parkinson's disease. The French Clozapine Parkinson Study Group.
    Lancet; 1999 Jun; 353(9169):2041-2. PubMed ID: 10376627
    [No Abstract]   [Full Text] [Related]  

  • 31. Intrahippocampal scopolamine impairs both acquisition and consolidation of contextual fear conditioning.
    Wallenstein GV; Vago DR
    Neurobiol Learn Mem; 2001 May; 75(3):245-52. PubMed ID: 11300731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Presumed central anticholinergic syndrome from inadvertent intravenous hyoscine hydrobromide (scopolamine) injection.
    Wilden J; Rapeport D
    Anaesth Intensive Care; 2004 Jun; 32(3):419-22. PubMed ID: 15264742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperthermia associated with central anticholinergic syndrome caused by a transdermal hyoscine patch in a child with cerebral palsy.
    Frampton A; Spinks J
    Emerg Med J; 2005 Sep; 22(9):678-9. PubMed ID: 16113205
    [No Abstract]   [Full Text] [Related]  

  • 34. Transdermally administered scopolamine.
    Paasuke RT
    CMAJ; 1985 Nov; 133(10):956. PubMed ID: 4063911
    [No Abstract]   [Full Text] [Related]  

  • 35. [Toxic psychoses from atropine and scopolamine].
    Müller J; Wanke K
    Fortschr Neurol Psychiatr; 1998 Jul; 66(7):289-95. PubMed ID: 9697003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Scopolamine-induced acute brain syndrome.
    Goldstein BJ
    J Fla Med Assoc; 1966 May; 53(5):413-4. PubMed ID: 5909711
    [No Abstract]   [Full Text] [Related]  

  • 37. Scopolamine bioavailability in combined oral and transdermal delivery.
    Nachum Z; Shahal B; Shupak A; Spitzer O; Gonen A; Beiran I; Lavon H; Eynan M; Dachir S; Levy A
    J Pharmacol Exp Ther; 2001 Jan; 296(1):121-3. PubMed ID: 11123371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Anticholinergic drugs and CNS relevance for therapy].
    Madersbacher H
    Krankenpfl J; 2005; 43(7-10):187-8. PubMed ID: 16515260
    [No Abstract]   [Full Text] [Related]  

  • 39. Managing psychosis in patients with Parkinson's disease.
    Cummings JL
    N Engl J Med; 1999 Mar; 340(10):801-3. PubMed ID: 10072418
    [No Abstract]   [Full Text] [Related]  

  • 40. Psychotic symptoms resulting from intraventricular infusion of dopamine in Parkinson's disease.
    Kulkarni J; Horne M; Butler E; Keks N; Copolov D
    Biol Psychiatry; 1992 Jun; 31(12):1225-7. PubMed ID: 1391283
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.